HomepageEarnings Events Newsdesk 4 years ago Lonza Group Ltd (LONN) 26 January 2022 | Full-Year Results 2021 Lonza Group Ltd (BRZ: LONN) Q4 2021 Earnings Conference Immunocore Holdings Limited (IMCR) Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma » « KEPPEL INFRASTRUCTURE TRUST (KIT) 4Q21 Earnings Call Newsdesk: